查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2108276

基因組學領域人工智慧市場到 2035 年前的分析和預測：按類型、產品、服務、技術、組件、應用、流程和最終用戶分類。

Artificial Intelligence In Genomics Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Process, End User
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球基因組學人工智慧（AI）市場預計將從2025年的16億美元成長到2035年的116億美元，複合年成長率（CAGR）為22.0%。基因組學人工智慧市場的成長主要受基因組測序的日益普及、精準醫療需求的不斷成長以及對複雜生物數據進行更快更準確分析的需求所驅動。據全球衛生和研究機構稱，由於測序工作的不斷推進和全球範圍內大規模人群調查的開展，基因組資料集正在迅速擴展。人工智慧、機器學習和先進分析技術的融合，能夠有效解讀突變、預測疾病、發現藥物並制定個人化治療策略，從而推動腫瘤學、罕見疾病和遺傳疾病研究的進展。

基因組學領域人工智慧市場的「類型」細分包括機器學習、深度學習、自然語言處理和電腦視覺。其中，機器學習和深度學習佔了大部分市場佔有率，因為它們被廣泛應用於基因組數據分析、突變解讀、預測建模以及疾病相關基因模式的識別。深度學習演算法能夠處理大型高維度生物資料集，因此擴大被應用於基因組定序分析、生物標記發現和個人化醫療等複雜的基因組應用。自然語言處理在從生物醫學文獻、電子健康記錄和臨床基因組報告中提取資訊方面正變得越來越重要，而電腦視覺則為醫學成像和空間基因組分析等應用提供支援。

市場區隔
類型 機器學習、深度學習、自然語言處理、電腦視覺等
產品 軟體工具、平台、人工智慧整合基因組定序儀等。
服務 諮詢、實施和整合、支援和維護、培訓和教育以及其他服務。
科技 雲端部署、本地部署、混合部署及其他
成分 硬體、軟體、服務及其他
目的 藥物發現、精準醫療、診斷、臨床研究、功能基因體學等。
過程 數據分析、定序、基因編輯等。
最終用戶 製藥公司、研究機構、醫療保健組織、生技公司及其他

人工智慧在基因組學領域的應用涵蓋藥物發現、精準醫療、診斷、臨床研究、功能基因體學等多個面向。藥物發現是其中一項主要應用，人工智慧驅動的基因組分析在標靶識別、分子篩檢和個人化療法開發中的應用日益廣泛。精準醫療正經歷快速成長，人工智慧能夠整合基因組數據和臨床訊息，從而支持個人化治療策略並改善患者預後。診斷領域也不斷拓展，基於人工智慧的基因組分析工具能夠實現疾病檢測、提高基因檢測的準確性以及早期發現遺傳疾病。此外，人工智慧透過加速複雜生物資料集的分析、加深對基因功能的理解以及支持新型療法的開發，正在推動臨床研究和功能基因組學的發展。

區域概覽

到2025年，北美將佔基因組學人工智慧市場最大的佔有率，這得益於其強大的基因組研究生態系統、人工智慧技術的廣泛應用以及對精準醫療的大量投資。該地區匯集了許多領先的生物技術公司、基因組定序公司、人工智慧開發公司以及知名研究機構，這些機構正積極將機器學習應用於基因組數據分析、藥物研發和疾病預測。政府對基因組研究的大力投入、有利的監管支持以及製藥公司與人工智慧技術提供商之間日益密切的合作，進一步加速了市場成長。此外，基於雲端的生物資訊平台和高性能定序技術的快速發展，也將持續鞏固北美在全球基因組學人工智慧市場的主導地位。

在亞太地區，基因組研究計畫的拓展、醫療數位化進程的推進以及對人工智慧和生物技術投資的增加，預計將推動基因組領域人工智慧市場實現最高成長率。中國、印度、日本、韓國和新加坡等國家正透過國家級精準醫療舉措和大規模人群定序項目，持續提升其基因組定序能力。對個人化醫療日益成長的需求、醫療基礎設施的改善以及研究機構、醫療服務提供者和人工智慧公司之間合作的加強，進一步推動了該地區的市場擴張。此外，政府的支持措施、基因組資料集的日益豐富以及人工智慧驅動的診斷和藥物研發平台的廣泛應用，預計將使亞太地區在預測期內成為成長最快的區域市場。

主要趨勢和促進因素

將生成式人工智慧和多模態分析整合到基因組研究中

在基因組學領域的人工智慧市場細分中，生成式人工智慧和多模態分析平台正蓬勃發展，這些平台整合了基因組、轉錄組、蛋白質組、影像和臨床數據。這些先進的人工智慧模型使研究人員能夠更快、更準確地識別疾病相關的基因變異、預測治療反應並發現新的藥物標靶。基於雲端的人工智慧平台也透過支援大規模基因組數據分析，加強了研究機構和醫療服務提供者之間的合作。隨著精準醫療在全球範圍內的推進，將先進的人工智慧演算法整合到基因組分析工作流程中正成為推動研究和臨床應用創新發展的關鍵趨勢。

精準醫療和大規模基因組定序的需求日益成長

精準醫療的日益普及和大規模基因組定序計畫的快速發展是基因組學領域人工智慧市場的主要驅動力。定序成本的降低和新一代定序（NGS）技術的進步正在產生大量的基因組數據，使得人工智慧工具對於高效分析至關重要。製藥公司、生物技術公司和研究機構正在利用人工智慧加速生物標記的發現、患者分層和藥物研發。此外，癌症、罕見遺傳疾病和慢性病的日益普遍也增加了對個人化醫療的需求，進一步推動了對人工智慧基因組分析平台和臨床研究的投資。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 機器學習
    • 深度學習
    • 自然語言處理
    • 電腦視覺
    • 其他
  • 市場規模及預測：依產品分類
    • 軟體工具
    • 平台
    • 人工智慧整合基因組定序儀
    • 其他
  • 市場規模及預測：依服務分類
    • 諮詢
    • 實施與整合
    • 支援與維護
    • 培訓和教育
    • 其他
  • 市場規模及預測：依技術分類
    • 基於雲端的
    • 本地部署
    • 混合型
    • 其他
  • 市場規模及預測：依組件分類
    • 硬體
    • 軟體
    • 服務
    • 其他
  • 市場規模及預測：依應用領域分類
    • 藥物發現
    • 精準醫療
    • 診斷
    • 臨床研究
    • 功能基因體學
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 製藥公司
    • 研究機構
    • 醫療機構
    • 生技公司
    • 其他
  • 市場規模及預測：依製程分類
    • 數據分析
    • 順序
    • 基因編輯
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 定價和成本利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • Illumina
  • Thermo Fisher Scientific
  • IBM
  • Google DeepMind
  • Microsoft
  • NVIDIA
  • Fujitsu
  • Qiagen
  • BenevolentAI
  • Genoox
  • Fabric Genomics
  • SOPHiA GENETICS
  • Deep Genomics
  • Insilico Medicine
  • Grail
  • Verge Genomics
  • Tempus
  • PathAI
  • Recursion Pharmaceuticals
  • CureMetrix

第9章 關於我們

簡介目錄
Product Code: GIS20765

The global Artificial Intelligence in Genomics Market is projected to grow from $1.6 billion in 2025 to $11.6 billion by 2035, at a compound annual growth rate (CAGR) of 22.0%. The artificial intelligence in genomics market is driven by the increasing adoption of genomic sequencing, rising demand for precision medicine, and the need for faster and more accurate analysis of complex biological data. According to global health and research organizations, genomic datasets are expanding rapidly due to growing sequencing initiatives and large-scale population studies worldwide. The integration of artificial intelligence, machine learning, and advanced analytics is enabling efficient variant interpretation, disease prediction, drug discovery, and personalized treatment strategies, supporting advancements across oncology, rare diseases, and genetic disorder research.

The Type segment of the Artificial Intelligence in Genomics Market includes machine learning, deep learning, natural language processing, computer vision, and others. Among these, machine learning and deep learning account for significant market shares due to their widespread use in genomic data analysis, variant interpretation, predictive modeling, and identification of disease-related genetic patterns. Deep learning algorithms are increasingly adopted for complex genomic applications, including genome sequencing analysis, biomarker discovery, and personalized medicine, as they can process large-scale and high-dimensional biological datasets. Natural language processing is gaining importance for extracting insights from biomedical literature, electronic health records, and clinical genomic reports, while computer vision supports applications involving medical imaging and spatial genomics analysis.

Market Segmentation
TypeMachine Learning, Deep Learning, Natural Language Processing, Computer Vision, Others
ProductSoftware Tools, Platforms, AI-Integrated Genomic Sequencers, Others
ServicesConsulting, Deployment and Integration, Support and Maintenance, Training and Education, Others
TechnologyCloud-Based, On-Premises, Hybrid, Others
ComponentHardware, Software, Services, Others
ApplicationDrug Discovery, Precision Medicine, Diagnostics, Clinical Research, Functional Genomics, Others
ProcessData Analysis, Sequencing, Gene Editing, Others
End UserPharmaceutical Companies, Research Institutes, Healthcare Providers, Biotechnology Companies, Others

The Application segment of the Artificial Intelligence in Genomics Market includes drug discovery, precision medicine, diagnostics, clinical research, functional genomics, and others. Drug discovery represents a major application area due to the increasing adoption of AI-driven genomic analysis for target identification, molecular screening, and development of personalized therapies. Precision medicine is witnessing rapid growth as AI enables the integration of genomic data with clinical information to support individualized treatment strategies and improve patient outcomes. Diagnostics are expanding due to AI-based genomic tools that enhance disease detection, genetic testing accuracy, and early identification of inherited disorders. Additionally, AI is accelerating clinical research and functional genomics by enabling faster analysis of complex biological datasets, improving understanding of gene functions, and supporting the development of novel therapeutic approaches.

Geographical Overview

North America held the largest share of the artificial intelligence in genomics market in 2025, supported by its robust genomics research ecosystem, widespread adoption of artificial intelligence technologies, and substantial investments in precision medicine. The region is home to leading biotechnology companies, genomic sequencing firms, AI developers, and renowned research institutions that actively integrate machine learning into genomic data analysis, drug discovery, and disease prediction. Strong government funding for genomic research, favorable regulatory support, and increasing collaborations between pharmaceutical companies and AI technology providers have further accelerated market growth. Additionally, the rapid adoption of cloud-based bioinformatics platforms and high-throughput sequencing technologies continues to reinforce North America's leadership in the global AI in genomics market.

Asia Pacific is expected to register the highest growth in the artificial intelligence in genomics market due to expanding genomics research programs, increasing healthcare digitalization, and growing investments in artificial intelligence and biotechnology. Countries such as China, India, Japan, South Korea, and Singapore are strengthening their genomic sequencing capabilities through national precision medicine initiatives and large-scale population genomics projects. Rising demand for personalized medicine, improving healthcare infrastructure, and increasing collaborations between research institutions, healthcare providers, and AI companies are further driving regional market expansion. Moreover, supportive government policies, growing availability of genomic datasets, and increasing adoption of AI-powered diagnostic and drug discovery platforms are expected to position Asia Pacific as the fastest-growing regional market over the forecast period.

Key Trends and Drivers

Integration of Generative AI and Multimodal Analytics in Genomic Research:

The artificial intelligence in genomics market is witnessing a strong trend toward the adoption of generative AI and multimodal analytics platforms that integrate genomic, transcriptomic, proteomic, imaging, and clinical data. These advanced AI models enable researchers to identify disease-associated genetic variants, predict therapeutic responses, and discover novel drug targets with greater speed and accuracy. Cloud-based AI platforms are also improving collaboration among research institutions and healthcare providers by enabling large-scale genomic data analysis. As precision medicine initiatives expand globally, the integration of sophisticated AI algorithms into genomic workflows is becoming a key trend driving innovation across research and clinical applications.

Growing Demand for Precision Medicine and Large-Scale Genomic Sequencing:

The increasing adoption of precision medicine and the rapid expansion of large-scale genomic sequencing projects are major drivers of the artificial intelligence in genomics market. Declining sequencing costs and advancements in next-generation sequencing (NGS) technologies have generated enormous volumes of genomic data that require AI-powered tools for efficient interpretation. Pharmaceutical companies, biotechnology firms, and research organizations are leveraging AI to accelerate biomarker discovery, patient stratification, and drug development. Additionally, the rising prevalence of cancer, rare genetic disorders, and chronic diseases is increasing the demand for personalized treatment approaches, further boosting investments in AI-enabled genomic analysis platforms and clinical research.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Process

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Machine Learning
    • 4.1.2 Deep Learning
    • 4.1.3 Natural Language Processing
    • 4.1.4 Computer Vision
    • 4.1.5 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Software Tools
    • 4.2.2 Platforms
    • 4.2.3 AI-Integrated Genomic Sequencers
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting
    • 4.3.2 Deployment and Integration
    • 4.3.3 Support and Maintenance
    • 4.3.4 Training and Education
    • 4.3.5 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Cloud-Based
    • 4.4.2 On-Premises
    • 4.4.3 Hybrid
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
    • 4.5.3 Services
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Drug Discovery
    • 4.6.2 Precision Medicine
    • 4.6.3 Diagnostics
    • 4.6.4 Clinical Research
    • 4.6.5 Functional Genomics
    • 4.6.6 Others
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Pharmaceutical Companies
    • 4.7.2 Research Institutes
    • 4.7.3 Healthcare Providers
    • 4.7.4 Biotechnology Companies
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Data Analysis
    • 4.8.2 Sequencing
    • 4.8.3 Gene Editing
    • 4.8.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Process
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Process
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Process
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Process
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Process
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Process
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Process
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Process
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Process
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Process
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Process
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Process
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Process
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Process
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Process
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Process
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Process
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Process
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Process
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Process
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Process
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Process
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Process
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Process

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Illumina
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Thermo Fisher Scientific
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 IBM
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Google DeepMind
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Microsoft
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 NVIDIA
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Fujitsu
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Qiagen
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 BenevolentAI
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Genoox
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Fabric Genomics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 SOPHiA GENETICS
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Deep Genomics
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Insilico Medicine
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Grail
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Verge Genomics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Tempus
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 PathAI
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Recursion Pharmaceuticals
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 CureMetrix
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us